EmVenio Blog
Webinar: Bringing Clinical Trial Access to Underserved Populations in a Community Setting
Clinical trials are an important healthcare option, presenting benefits to patients, physicians and the broader community. Yet, relatively low enrollment rates have continued to be a bottleneck for clinical trials. In traditional research settings, about four percent...
EmVenio Research prioritizes improving access to clinical research in Chicago with opening of community research site
DURHAM, N.C., May 18, 2023 /PRNewswire/ -- EmVenio Research activated a mobile community research site in Chicago, Illinois, on the Illinois Medical District campus as part of a concerted effort to maximize diversity, equity and inclusion in research studies and...
EmVenio Research and Socially Determined partner to optimize recruitment, retention and representation in clinical trials
Durham, NC - May 17, 2023 – EmVenio Research, a company providing rapid and scalable mobile research sites in order to better reach and recruit diverse, underserved and high-risk communities, has partnered with Socially Determined, a social risk analytics and...
World Vaccine Congress 2023
EmVenio Research attended the World Vaccine Congress in Washington DC earlier this month. The conference, which took place from April 3rd to 6th, brought together industry leaders, scientists, and researchers from around the world to discuss the latest advancements in...
EmVenio Research March 2023 Community Engagement Overview
EmVenio Research’s dedication to the community is demonstrated by action. Our passion for engaging local communities is what sets us apart. On March 6th, our mobile Community Research Site was on campus! The students from Georgia Tech School of Industrial Design and...
EmVenio Research names new chief medical officer
DURHAM, N.C., April 11, 2023 /PRNewswire/ -- EmVenio Research today announced the appointment of Dr. Mark McKenzie, M.D. as its chief medical officer. In this role, Dr. McKenzie will lead and strategize new initiatives in the clinical and...
EmVenio Research Partners with ClearDATA to Secure Clinical Trials in the Heart of Underserved Communities
EmVenio doubles minority participation in clinical trials with geographic and cultural accessibility solution protected by the ClearDATA Managed Health Cloud AUSTIN, Texas, March 30, 2023 (GLOBE NEWSWIRE) -- ClearDATA®, the first and most comprehensive provider...
EmVenio featured in CenterWatch
EmVenio president Thad Wolfram spoke to CenterWatch about our innovative approach to expand access and diversity in clinical trials through our fleet of mobile community research sites. Thad discussed how EmVenio was formed and its mission behind the work we do. Read...
EmVenio Research prioritizes improving access to clinical research in Orlando with opening of community research site
DURHAM, N.C., March 6, 2023 /PRNewswire/ -- EmVenio Research activated a mobile community research site in Orlando, Florida, as part of a concerted effort to maximize diversity, equity and inclusion in research studies and deliver clinical...
Activated Sites
EmVenio Research is committed to helping you achieve your DEI objectives and meet enrollment goals. With our 10 active Community Research Sites located in geographies providing access to underserved and difficult to reach populations, we enable you to enroll the...
SCOPE Summit 2023
The SCOPE 2023 Summit was a major success, with attendees from all over the world gathering to learn more about the latest developments in the clinical trial industry. The event was full of memorable moments, from keynotes, workshops, and demos to the SCOPE 2023 Best...
EmVenio Research prioritizes improving access to clinical research with the opening of the Claremont Community Research Site
DURHAM, N.C., Feb. 21, 2023 /PRNewswire/ -- EmVenio Research activated a mobile community research site in Claremont, California, as part of a concerted effort to maximize diversity, equity and inclusion in research studies and deliver...
EmVenio prioritizes inclusion in clinical research with new patient-centric model
DURHAM, N.C., Feb. 16, 2023 – In an effort to maximize diversity, equity and inclusion in clinical research, EmVenio Research activated 10 community research sites among diverse populations across the United States. This concerted effort marks the value EmVenio’s...
GeoVax and EmVenio Announce Collaboration to Expand Phase 2 COVID-19 Booster Vaccine Clinical Trial
Mobile Community Clinical Research Facility to be Deployed in California Atlanta, GA, February 15, 2023 – GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, and EmVenio Research, a...
Putting Patients First: The Benefits of Decentralized Clinical Trials
Clinical trials are essential for the discovery of new treatments and support the development of new life-saving drugs and medical devices that can benefit millions worldwide. But one of the greatest challenges in clinical research is the lack of representation.